Compare WIX & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WIX | INDV |
|---|---|---|
| Founded | 2006 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 4.4B |
| IPO Year | 2013 | 2014 |
| Metric | WIX | INDV |
|---|---|---|
| Price | $51.50 | $40.48 |
| Analyst Decision | Buy | |
| Analyst Count | 22 | 0 |
| Target Price | ★ $134.67 | N/A |
| AVG Volume (30 Days) | 1.2M | ★ 1.6M |
| Earning Date | 05-13-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 0.69 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $15.80 | N/A |
| Revenue Next Year | $13.21 | N/A |
| P/E Ratio | ★ $28.86 | $58.71 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $40.00 | $16.69 |
| 52 Week High | $190.92 | $42.81 |
| Indicator | WIX | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 53.41 | 53.87 |
| Support Level | $51.60 | $39.20 |
| Resistance Level | $54.55 | $41.42 |
| Average True Range (ATR) | 2.71 | 1.37 |
| MACD | 0.31 | -0.15 |
| Stochastic Oscillator | 70.21 | 56.03 |
Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years, it has invested heavily and introduced its Wix Studio offering for partners, which are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).